EasySep™小鼠TIL（CD45）正选试剂盒
关于我们
-
Swiss Society of Allergology and Immunology (SSAI) 2016 Annual Meeting Visit STEMCELL Technologies at booth #56 during SSAI 2016. -
Working in BioTech: Going Over To The Dark Side or Seeing The Light? STEMCELL's founder and CEO Dr. Allen Eaves presents his insights on entrepreneurship in today's biotechnology climate and its role in driving scientific advancement.
-
STEMCELL Technologies Will Test BioLife Solutions' evo™ Smart Shipper and Cloud Based biologistex™ Cold Chain Management App BioLife Solutions Inc. announced that privately held, Vancouver, BC-based STEMCELL Technologies will test BioLife's evo Smart Shipper and biologistex cold chain SaaS on a variety of temperature sensitive products for research in areas such as cellular therapies, blood cancers, and solid tumors -
Standardization of the Hematopoietic Progenitor Assay Training Course Apply now to reserve your space in our two-day training course specifically targeted to participants working with human hematopoietic samples.
-
iPS Cells to Neural Progenitors Training Course: Reprogramming, Maintenance and Differentiation Apply now to reserve your space in our three-day course that covers the entire workflow of reprogramming somatic cells to induced pluripotent stem (iPS) cells, the maintenance of human embryonic stem (ES) and iPS cells and their differentiation into neural progenitor cells (NPCs).
-
Applications of the Hematopoietic Progenitor Assay Training Course Apply now to reserve your space in our two-day training course focusing on hematopoietic progenitor assays for human, mouse, rat and dog samples with an emphasis on applying the colony forming unit (CFU) assay to your research.
-
Keystone Symposia - Cancer Immunotherapy: Immunity and Immunosuppression Meet Target Therapies (J6) Visit STEMCELL Technologies during Poster Session 2 in the Pacific Ballroom.
-
BCTECH Summit STEMCELL Technologies is British Columbia's largest biotech company and you can come visit our booth on both days of the #BCTECH Summit in the Vancouver Convention Centre.
-
STEMCELL Technologies to Commercialize BrainPhys™ Neuronal Culture Medium for Improved Support of Neurophysiological Activity STEMCELL Technologies has announced that it has signed a license agreement with the Salk Institute for Biological Studies for the rights to commercialize BrainPhys™ Neuronal Medium -
STEMCELL Technologies Receives ISO 13845:2003 Certification STEMCELL Technologies Inc (STEMCELL), a leader in specialty cell culture media, cell separation products and ancillary reagents for life science research, is pleased to announce that it has successfully achieved ISO 13485:2003 certification for its research, manufacturing and shipping facilities in Vancouver, BC, Canada and Tukwila, WA, USA
